THE ADNEXAL MASS - BENIGN OR MALIGNANT - EVALUATION OF A RISK OF MALIGNANCY INDEX

被引:96
作者
DAVIES, AP
JACOBS, I
WOOLAS, R
FISH, A
ORAM, D
机构
[1] UNIV CAMBRIDGE,ROSIE MATERN HOSP,DEPT OBSTET & GYNAECOL,CAMBRIDGE,ENGLAND
[2] ROYAL LONDON HOSP,DEPT GYNAECOL ONCOL,LONDON,ENGLAND
来源
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1993年 / 100卷 / 10期
关键词
D O I
10.1111/j.1471-0528.1993.tb15109.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To validate a risk of malignancy index incorporating menopausal status, serum CA 125 level and pelvic ultrasound features in the pre-operative diagnosis of ovarian cancer. Design A retrospective observational study. Setting Department of Obstetrics and Gynaecology, The Royal London Hospital. Subjects One hundred and twenty-four women admitted consecutively to the gynaecology department for surgical exploration of an adnexal mass. Main outcome measures The sensitivities and specificities of menopausal status, serum CA 125 level and ultrasound features, in isolation and combined (the risk of malignancy index (RMI)), for diagnosing ovarian cancer. Results Tested on a new population of women, the RMI retained the high sensitivity for diagnosing ovarian cancer seen in the original report describing its derivation. The specificity, however, was lower. The study confirmed that the RMI is more accurate than the individual criteria in diagnosing ovarian cancer, and was comparable with other scoring systems. Conclusions The risk of malignancy index is a simple scoring system for ovarian cancer. Application of the risk of malignancy index in clinical practice may provide a rational basis for specialist referral of patients with ovarian cancer before diagnostic surgery.
引用
收藏
页码:927 / 931
页数:5
相关论文
共 24 条
[1]   A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].
BAST, RC ;
KLUG, TL ;
STJOHN, E ;
JENISON, E ;
NILOFF, JM ;
LAZARUS, H ;
BERKOWITZ, RS ;
LEAVITT, T ;
GRIFFITHS, CT ;
PARKER, L ;
ZURAWSKI, VR ;
KNAPP, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887
[2]  
BAST RC, 1990, OVARIAN CANCER BIOL, P265
[3]  
BENACERRAF BR, 1990, J REPROD MED, V35, P491
[4]   TRANS-VAGINAL COLOR FLOW IMAGING - A POSSIBLE NEW SCREENING TECHNIQUE FOR OVARIAN-CANCER [J].
BOURNE, T ;
CAMPBELL, S ;
STEER, C ;
WHITEHEAD, MI ;
COLLINS, WP .
BRITISH MEDICAL JOURNAL, 1989, 299 (6712) :1367-1370
[5]   THE CLINICAL-SIGNIFICANCE OF PREOPERATIVE SERUM CA-125 IN OVARIAN-CANCER [J].
CRUICKSHANK, DJ ;
FULLERTON, WT ;
KLOPPER, A .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (07) :692-695
[6]  
DELAND M, 1979, SURG GYNECOL OBSTET, V148, P346
[7]   CA-125 ASSAY USED IN CONJUNCTION WITH CA-15-3 AND TAG-72 ASSAYS FOR DISCRIMINATION BETWEEN MALIGNANT AND NON-MALIGNANT DISEASES OF THE OVARY [J].
EINHORN, N ;
KNAPP, RC ;
BAST, RC ;
ZURAWSKI, VR .
ACTA ONCOLOGICA, 1989, 28 (05) :655-657
[8]  
FINKLER NJ, 1988, OBSTET GYNECOL, V72, P659
[9]  
FLEISCHER AC, 1988, DIAGN IMAGING, V10, P124
[10]  
GADDUCCI A, 1988, EUR J GYNAECOL ONCOL, V5, P373